GLPwatch
Trials (2095)
Page 11 of 35.
- The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
- Dietary Peanuts and Nutrition-Related Outcomes
- Semaglutide Therapy for Alcohol Reduction (STAR)
- A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity
- A Research Study Looking at Long-term Blood Sugar Control in People With Type 2 Diabetes Being Treated With Xultophy® in a Real-world Setting in Italy
- A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times
- Imaging Pituitary ActiVation by Exendin
- Pharmacogenetics of Response to GLP1R Agonists
- Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
- HbA1c Variability in Type II Diabetes
- A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes
- Safety and Efficacy of Liraglutide in Parkinson's Disease
- Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
- Tirzepatide and Muscle Outcomes in Obesity
- Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes Mellitus
- Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes
- Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study
- Semaglutide for Smoking Cessation in Patients With Diabetes
- Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study)
- Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)
- Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.
- Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes
- Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes
- Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
- Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)
- Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes
- The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
- O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Plan to Fast During Ramadan in the United Arab Emirates, Saudi Arabia, and Kuwait
- The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure
- The Use of Liraglutide in Brain Death
- A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
- Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
- Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents
- Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity
- Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disorder
- A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
- Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea
- GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)
- Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)
- A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)
- A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination
- Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg
- Human Bioequivalence Test of Liraglutide Injection
- Bariatric Surgery Combined With GLP-1 Receptor Agonists Study
- Liraglutide In Overweight Patients With Type 1 Diabetes
- Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
- Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
- Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome
- Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin
- A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.
- A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Participants
- Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice